They also discovered that co-inhibitory signaling through TIM3 and TIGIT may be a major driver of T cell exhaustion and highlighted that HBV infection could influence DLBCL progression by promoting malignant cell survival or inducing immune escape (48). The gene discussed is HAVCR2; the disease is diffuse large B-cell lymphoma.